Angelo Gordon & Co’s AdaptHealth AHCO Stock Holding History

Angelo Gordon & Co’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,924	Closed	-$299K	–	233
2021 Q2	$299K	Hold	10,924	–	–	0.02%	173
2021 Q1	$402K	Hold	10,924	–	–	0.04%	160
2020 Q4	$410K	Hold	10,924	–	–	0.04%	85
2020 Q3	$238K	Buy	+10,924	New	+$229K	0.03%	88
2019 Q4	–	Sell	-400,000	Closed	-$4.07M	–	70
2019 Q3	$4.07M	Sell	400,000 -200,000	-33%	-$2.04M	0.52%	35
2019 Q2	$6.08M	Hold	600,000	–	–	0.69%	39
2019 Q1	$5.99M	Hold	600,000	–	–	0.56%	42
2018 Q4	$5.9M	Hold	600,000	–	–	0.37%	46
2018 Q3	$5.83M	Hold	600,000	–	–	0.46%	53
2018 Q2	$5.77M	Buy	+600,000	New	+$5.82M	0.37%	66

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Angelo Gordon & Co's AHCO Position: Q3 2021 in Review

Angelo Gordon & Co sold out of AdaptHealth (AHCO) in Q3 2021, closing a stake of 10,924 shares — an estimated $299K sold.

Angelo Gordon & Co first reported a position in AHCO in Q2 2018 and held it in 10 quarters. The position peaked at $6.08M in Q2 2019. 142 funds tracked by Wall St. Rank hold AHCO as of Q3 2021.

Angelo Gordon & Co reported no remaining AdaptHealth position as of Q3 2021 after selling out during the quarter.
Angelo Gordon & Co sold 10,924 AdaptHealth shares in Q3 2021, an estimated $299K.
Angelo Gordon & Co first reported a position in AdaptHealth in Q2 2018 and held it in 10 quarters.
Angelo Gordon & Co's AdaptHealth position peaked at $6.08M in Q2 2019.
142 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2021.

Based on Angelo Gordon & Co's 13F filing for Q3 2021, filed 15 Nov 2021.